High-Risk Clinical Trials in Guangzhou, Guangdong
8 recruitingGuangzhou, Guangdong, China
Showing 1–8 of 8 trials
Recruiting
Phase 2
A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.
High-Risk Localized Prostate Cancer
Bayer250 enrolled23 locationsNCT07450599
Recruiting
Phase 4
Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia
Perioperative Respiratory Adverse EventsHigh-RiskRespiratory Hypersensitivity+2 more
Sun Yat-sen University204 enrolled2 locationsNCT06624696
Recruiting
Not Applicable
Interventional Left Ventricular Assist System for PCI in CHIP Patients
High-Risk Percutaneous Coronary Intervention (High-risk PCI)Left Ventricular Assist Devices
Suzhou Hengruihongyuan Medical Technology Co. LTD286 enrolled15 locationsNCT07053618
Recruiting
Phase 2
SCRT + mFOLFOX6 + PD-1 Antibody + Targeted Therapy for HIgh-Risk pMMR/MSS Rectal Cancer
Rectal AdenocarcinomaHigh-Risk CancerMSS
Sixth Affiliated Hospital, Sun Yat-sen University49 enrolled1 locationNCT06908031
Recruiting
Phase 1Phase 2
To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2
High-risk Non-muscle Invasive Bladder Cancer
RemeGen Co., Ltd.24 enrolled6 locationsNCT06378242
Recruiting
Not Applicable
An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate Cancer
High-Risk and Oligometastatic Prostate Cancer
Zhujiang Hospital50 enrolled1 locationNCT04997252
Recruiting
Phase 3
Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)
Clinical High-risk Syndrome of Psychosis
Shanghai Jiao Tong University School of Medicine300 enrolled9 locationsNCT03932136
Recruiting
Not Applicable
Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer
Rectal CancerLocally AdvancedMSS+1 more
Nanfang Hospital, Southern Medical University53 enrolled1 locationNCT05877573